Cargando…

Correction to: Fluralaner 5.46% (w/w) favored chewable tablet (Bravecto® 1-Month) is effective for treatment of canine generalized demodicosis

Detalles Bibliográficos
Autores principales:	Rohdich, Nadja, Meyer, Leon, Guerino, Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994337/ https://www.ncbi.nlm.nih.gov/pubmed/35395813 http://dx.doi.org/10.1186/s13071-022-05256-0

Ejemplares similares

Fluralaner 5.46% (w/w) flavored chewable tablet (Bravecto(®) 1-Month) is effective for treatment of canine generalized demodicosis
por: Rohdich, Nadja, et al.
Publicado: (2022)

Efficacy of fluralaner chewable tablets (Bravecto(®)) against Asian longhorned tick (Haemaphysalis longicornis) infestations of dogs
por: Petersen, Melissa, et al.
Publicado: (2023)

A European field assessment of the efficacy of fluralaner (Bravecto(®)) chewable and spot-on formulations for treatment of dogs with generalized demodicosis
por: Petersen, Ivo, et al.
Publicado: (2020)

Efficacy of fluralaner (Bravecto™ chewable tablets) for the treatment of naturally acquired Linognathus setosus infestations on dogs
por: Kohler-Aanesen, Heike, et al.
Publicado: (2017)

Prevention of transmission of Babesia canis by Dermacentor reticulatus ticks to dogs treated orally with fluralaner chewable tablets (Bravecto™)
por: Taenzler, Janina, et al.
Publicado: (2015)

Safety of fluralaner chewable tablets (Bravecto(TM)), a novel systemic antiparasitic drug, in dogs after oral administration
por: Walther, Feli M, et al.
Publicado: (2014)

Field efficacy of fluralaner (Bravecto(®) chewable tablets) for preventing Babesia canis infection transmitted by Dermacentor reticulatus ticks to dogs
por: Chiummo, Rafael, et al.
Publicado: (2023)

Comparative speed of kill of sarolaner (Simparica™ Chewables) and fluralaner (Bravecto(®)) against induced infestations of Amblyomma americanum on dogs
por: Six, Robert H., et al.
Publicado: (2016)

Efficacy of orally administered fluralaner (Bravecto(TM)) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs
por: Fourie, Josephus J, et al.
Publicado: (2015)

Treatment of dogs with Bravecto(®) (fluralaner) reduces mosquito survival and fecundity
por: Evans, Christopher Charles, et al.
Publicado: (2023)

Investigation of the efficacy of fluralaner spot-on (Bravecto®) against infestations of Ixodes holocyclus on cats
por: Fisara, Petr, et al.
Publicado: (2018)

Efficacy of two topical fluralaner formulations (Bravecto®; Bravecto® Plus) against Asian longhorned tick (Haemaphysalis longicornis) infestations of cats
por: Petersen, Melissa, et al.
Publicado: (2023)

A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of Bravecto™ (fluralaner) against Frontline™ (fipronil) in flea- and tick-infested dogs
por: Rohdich, Nadja, et al.
Publicado: (2014)

Publisher Correction: Efficacy of two topical fluralaner formulations (Bravecto®; Bravecto® Plus) against Asian longhorned tick (Haemaphysalis longicornis) infestations of cats
por: Petersen, Melissa, et al.
Publicado: (2023)

Efficacy of oral fluralaner for the treatment of canine generalized demodicosis: a molecular-level confirmation
por: Djuric, Milos, et al.
Publicado: (2019)

Fluralaner (Bravecto(®)) treatment kills Aedes aegypti after feeding on Dirofilaria immitis-infected dogs
por: Duncan, Kathryn, et al.
Publicado: (2023)

Onset of activity of fluralaner (BRAVECTO™) against Ctenocephalides felis on dogs
por: Taenzler, Janina, et al.
Publicado: (2014)

Evaluation of oral fluralaner (Bravecto(®)) for efficacy against nymphs of Amblyomma americanum and Rhipicephalus sanguineus (sensu lato)
por: Allen, Kelly, et al.
Publicado: (2020)

Efficacy of Bravecto(®) Plus spot-on solution for cats (280 mg/ml fluralaner and 14 mg/ml moxidectin) for the prevention of aelurostrongylosis in experimentally infected cats
por: Raue, Katharina, et al.
Publicado: (2021)

Safety of the concurrent treatment of dogs with Bravecto™ (fluralaner) and Scalibor™ protectorband (deltamethrin)
por: Walther, Feli M, et al.
Publicado: (2014)

Safety of concurrent treatment of dogs with fluralaner (Bravecto™) and milbemycin oxime - praziquantel
por: Walther, Feli M, et al.
Publicado: (2014)

The speed of kill of fluralaner (Bravecto™) against Ixodes ricinus ticks on dogs
por: Wengenmayer, Christina, et al.
Publicado: (2014)

Year-round efficacy of a single treatment of fluralaner injectable suspension (Bravecto Quantum(TM)) against repeated infestations with Ixodes holocyclus in dogs
por: Fisara, Petr, et al.
Publicado: (2023)

Efficacy of topically administered fluralaner or imidacloprid/moxidectin on dogs with generalised demodicosis
por: Fourie, Josephus J., et al.
Publicado: (2019)

Field effectiveness and safety of fluralaner plus moxidectin (Bravecto® Plus) against ticks and fleas: a European randomized, blinded, multicenter field study in naturally-infested client-owned cats
por: Rohdich, Nadja, et al.
Publicado: (2018)

A randomized, blinded, controlled, multi-centered field study assessing the treatment of gastrointestinal nematode infections in cats with fluralaner plus moxidectin spot-on solution (Bravecto® Plus)
por: Rohdich, Nadja, et al.
Publicado: (2018)

Plasma pharmacokinetic profile of fluralaner (Bravecto™) and ivermectin following concurrent administration to dogs
por: Walther, Feli M., et al.
Publicado: (2015)

A randomized, blinded, controlled USA field study to assess the use of fluralaner tablets in controlling canine flea infestations
por: Meadows, Cheyney, et al.
Publicado: (2014)

Efficacy of a spot-on combination of fluralaner plus moxidectin (Bravecto(®) Plus) in cats following repeated experimental challenge with a field isolate of Ctenocephalides felis
por: Fisara, Petr, et al.
Publicado: (2019)

Year-round efficacy of a single treatment of fluralaner injectable suspension (Bravecto Quantum™) against repeated infestations with Rhipicephalus sanguineus (sensu lato) and Ctenocephalides felis in dogs
por: Fisara, Petr, et al.
Publicado: (2023)

Suspected neurological toxicity after oral application of fluralaner (Bravecto®) in a Kooikerhondje dog
por: Gaens, Daniela, et al.
Publicado: (2019)

Efficacy of a topical application of Certifect(®) (fipronil 6.26% w/v, amitraz 7.48% w/v, (S)-methoprene 5.63% w/v) for the treatment of canine generalized demodicosis
por: Fourie, Josephus, et al.
Publicado: (2013)

Effectiveness of a fluralaner spot-on formulation in a case of feline demodicosis due to Demodex cati
por: Bouza-Rapti, Pavlina, et al.
Publicado: (2022)

Comparative speed of kill of sarolaner (Simparica(™)) and fluralaner (Bravecto(®)) against induced infestations of Ctenocephalides felis on dogs
por: Six, Robert H., et al.
Publicado: (2016)

Insecticidal efficacy of fluralaner (Bravecto(®)) against Triatoma brasiliensis, a major vector of Trypanosoma cruzi in Brazil
por: Queiroga, Tamyres Bernadete Dantas, et al.
Publicado: (2021)

Canine demodicosis: Hematological and biochemical alterations
por: Salem, N. Y., et al.
Publicado: (2020)

Efficacy of fluralaner plus moxidectin (Bravecto® Plus spot-on solution for cats) against Otodectes cynotis infestations in cats
por: Taenzler, Janina, et al.
Publicado: (2018)

Fluralaner (Bravecto®) induces long-term mortality of Lutzomyia longipalpis after a blood meal in treated dogs
por: Queiroga, Tamyres Bernadete Dantas, et al.
Publicado: (2020)

Efficacy of orally and topically administered fluralaner (Bravecto(®)) for treatment of client-owned dogs with sarcoptic mange under field conditions
por: Chiummo, Rafael, et al.
Publicado: (2020)

Efficacy of oral afoxolaner for the treatment of canine generalised demodicosis
por: Beugnet, Frédéric, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4s9ilridnub14bmpo4pr6bi4d2